About this Journal Submit a Manuscript Table of Contents
Mediators of Inflammation
Volume 2012 (2012), Article ID 260473, 7 pages
http://dx.doi.org/10.1155/2012/260473
Research Article

IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barré Syndrome

1Department of Neurology, The First Hospital, Jilin University, Jilin Province, Changchun 130021, China
2Department of Neurology, The Affiliated Hospital of Jiangsu University, Jiangsu Province, Zhenjiang 212001, China
3Department of Neurology, The Affiliated Hospital of Medical College, Qingdao University, Shandong Province, Qingdao 266003, China
4Department of Central Laboratory, The Second Part of the First Hospital, Jilin University, Jilin Province, Changchun 130032, China

Received 10 April 2012; Accepted 4 September 2012

Academic Editor: Sunil Kumar Manna

Copyright © 2012 Shujuan Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Hughes and D. R. Cornblath, “Guillain-Barré syndrome,” The Lancet, vol. 366, no. 9497, pp. 1653–1666, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Cosi and M. Versino, “Guillain-Barré syndrome,” Neurological Sciences, vol. 27, supplement 1, pp. s47–s51, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. Van Doorn, L. Ruts, and B. C. Jacobs, “Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome,” The Lancet Neurology, vol. 7, no. 10, pp. 939–950, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Perry, A. Fung, P. Poon, and N. Bayer, “Magnetic resonance imaging of nerve root inflammation in the Guillain-Barre syndrome,” Neuroradiology, vol. 36, no. 2, pp. 139–140, 1994. View at Scopus
  5. R. A. Hughes, J. C. Raphaël, A. V. Swan, and P. A. van Doorn, “Intravenous immunoglobulin for Guillain-Barré syndrome,” Cochrane Database of Systematic Reviews, no. 1, p. CD002063, 2006. View at Scopus
  6. J. C. Raphaël, S. Chevret, R. A. Hughes, and D. Annane, “Plasma exchange for Guillain-Barré syndrome,” Cochrane Database of Systematic Reviews, no. 2, p. CD001798, 2002. View at Scopus
  7. P. Miossec, “IL-17 and Th17 cells in human inflammatory diseases,” Microbes and Infection, vol. 11, no. 5, pp. 625–630, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. L. Gurney, “IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues,” International Immunopharmacology, vol. 4, no. 5, pp. 669–677, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. S. J. Aujla, Y. R. Chan, M. Zheng et al., “IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia,” Nature Medicine, vol. 14, no. 3, pp. 275–281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Zheng, P. A. Valdez, D. M. Danilenko et al., “Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens,” Nature Medicine, vol. 14, no. 3, pp. 282–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. L. A. Zenewicz and R. A. Flavell, “Recent advances in IL-22 biology,” International Immunology, vol. 23, no. 3, pp. 159–163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Matusevicius, P. Kivisäkk, B. He et al., “Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis,” Multiple Sclerosis, vol. 5, no. 2, pp. 101–104, 1999. View at Scopus
  13. S. A. Metawi, D. Abbas, M. M. Kamal, and M. K. Ibrahim, “Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA,” Clinical Rheumatology, vol. 30, no. 9, pp. 1201–1207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Fujino, A. Andoh, S. Bamba et al., “Increased expression of interleukin 17 in inflammatory bowel disease,” Gut, vol. 52, no. 1, pp. 65–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. H. Lo, K. Torii, C. Saito, T. Furuhashi, A. Maeda, and A. Morita, “Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy,” Journal of Dermatological Science, vol. 58, no. 3, pp. 225–227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Brand, F. Beigel, T. Olszak et al., “IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration,” American Journal of Physiology, vol. 290, no. 4, pp. G827–G838, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. D. Beyeen, M. Z. Adzemovic, J. Öckinger et al., “IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation,” Journal of Immunology, vol. 185, no. 11, pp. 6883–6890, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. K. Asbury and D. R. Cornblath, “Assessment of current diagnostic criteria for Guillain-Barre syndrome,” Annals of Neurology, vol. 27, supplement 1, pp. S21–S24, 1990. View at Publisher · View at Google Scholar · View at Scopus
  19. R. A. C. Hughes, J. M. Newsom-Davis, G. D. Perkin, and J. M. Pierce, “Controlled trial of prednisolone in acute polyneuropathy,” The Lancet, vol. 2, no. 8093, pp. 750–753, 1978. View at Scopus
  20. Y. Iwakura, H. Ishigame, S. Saijo, and S. Nakae, “Functional specialization of interleukin-17 family members,” Immunity, vol. 34, no. 2, pp. 149–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Wolk, E. Witte, K. Witte, K. Warszawska, and R. Sabat, “Biology of interleukin-22,” Seminars in Immunopathology, vol. 32, no. 1, pp. 17–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Ikeuchi, T. Kuroiwa, N. Hiramatsu et al., “Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine,” Arthritis and Rheumatism, vol. 52, no. 4, pp. 1037–1046, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. H. L. Zhang, S. Azimullah, X. Y. Zheng, et al., “IFN-γ, deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response,” Journal of Neuroimmunology, vol. 246, no. 1-2, pp. 18–26, 2012.
  24. Z. Zhang, Z. Y. Zhang, and H. J. Schluesener, “Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects,” Journal of Immunology, vol. 183, no. 5, pp. 3081–3091, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. L. J. Chi, W. H. Xu, Z. W. Zhang, H. T. Huang, L. M. Zhang, and J. Zhou, “Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy,” Journal of the Peripheral Nervous System, vol. 15, no. 4, pp. 345–356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Ghoreschi, A. Laurence, X. P. Yang et al., “Generation of pathogenic TH 17 cells in the absence of TGF-β 2 signalling,” Nature, vol. 467, no. 7318, pp. 967–971, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger, “TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells,” Immunity, vol. 24, no. 2, pp. 179–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. O. Lu and J. Zhu, “The role of cytokines in Guillain-Barré syndrome,” Journal of Neurology, vol. 258, no. 4, pp. 533–548, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. U. Nussinovitch and Y. Shoenfeld, “The role of gender and organ specific autoimmunity,” Autoimmunity Reviews, vol. 11, no. 6-7, pp. A377–A385, 2012.
  30. H. L. Chiang, R. K. Lyu, M. Y. Tseng et al., “Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders,” Clinica Chimica Acta, vol. 405, no. 1-2, pp. 143–147, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. B. C. Kieseier, R. Kiefer, R. Gold, B. Hemmer, H. J. Willison, and H. P. Hartung, “Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system,” Muscle and Nerve, vol. 30, no. 2, pp. 131–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Kebir, K. Kreymborg, I. Ifergan et al., “Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation,” Nature Medicine, vol. 13, no. 10, pp. 1173–1175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Kamm and U. K. Zettl, “Autoimmune disorders affecting both the central and peripheral nervous system,” Autoimmunity Reviews, vol. 11, no. 3, pp. 196–202, 2012. View at Publisher · View at Google Scholar · View at Scopus